학술논문
Manifesto on inhaled triple therapy in asthma: an Interasma (Global Asthma Association – GAA) document.
Document Type
Article
Author
Braido, Fulvio; Tiotiu, Angelica; Guidos-Fogelbach, Guillermo; Baiardini, Ilaria; Cosini, Filippo; Correia de Sousa, Jaime; Bikov, Andras; Novakova, Sylvia; Labor, Marina; Kaidashev, Igor; Nedeva, Denislava; Kowal, Krzysztof; Mihaicuta, Stefan; Urrutia Pereira, Marilyn; Solé, Dirceu; Novakova, Plamela; Chong-Neto, Herberto; Vrzy, Laura; Ansotegui, Ignacio J.; Bernstein, Jonathan A.
Source
Subject
*ASTHMA
*ADRENERGIC beta agonists
*MUSCARINIC antagonists
*MEDICAL research
*
*
*
Language
ISSN
0277-0903
Abstract
Objective: The optimal use of drug combinations for the management of asthma is providing significant results. This has prompted Interasma (Global Asthma Association) to take a position on inhaled triple therapy in asthma.Methods: We performed an extensive literature research to clinical trials, meta-analyses, randomized controlled trials and systematic reviews.Results: Starting from an extensive literature review, Interasma executive committee discussed and approved this Manifesto, developed by Interasma scientific network (INES) members.Conclusions: The manifesto describes the evidence gathered to date and states, advocates, and proposes issues on inhaled corticosteroid (ICS) plus long-acting beta 2 agonist (LABA) and long-acting muscarinic antagonists (LAMA) with the aim of challenging assumptions, fostering commitment, and bringing about change. [ABSTRACT FROM AUTHOR]